{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:48:00Z","timestamp":1791402480339,"version":"4.3.3"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T00:00:00Z","timestamp":1624492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","award":["G-15-0009282"],"award-info":[{"award-number":["G-15-0009282"]}],"id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]},{"name":"St. Michael\u2019s Hospital Foundation \u201cSCAR WARS\u201d program"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Patients with diabetes are at a high risk for developing cardiac dysfunction in the absence of coronary artery disease or hypertension, a condition known as diabetic cardiomyopathy. Contributing to heart failure is the presence of diabetic kidney disease. The Goto-Kakizaki (GK) rat is a non-obese, non-hypertensive model of type 2 diabetes that, like humans, shares a susceptibility locus on chromosome 10. Herein, we perform a detailed analysis of cardio-renal remodeling and response to renin angiotensin system blockade in GK rats to ascertain the validity of this model for further insights into disease pathogenesis.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Study 1: Male GK rats along with age matched Wistar control animals underwent longitudinal assessment of cardiac and renal function for 32 weeks (total age 48 weeks). Animals underwent regular echocardiography every 4 weeks and at sacrifice, early (~24 weeks) and late (~48 weeks) timepoints, along with pressure volume loop analysis. Histological and molecular characteristics were determined using standard techniques. Study 2: the effect of renin angiotensin system (RAS) blockade upon cardiac and renal function was assessed in GK rats. Finally, proteomic studies were conducted <jats:italic>in vivo<\/jats:italic> and <jats:italic>in vitro<\/jats:italic> to identify novel pathways involved in remodeling responses.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>GK rats developed hyperglycaemia by 12 weeks of age (p&lt;0.01 c\/w Wistar controls). Echocardiographic assessment of cardiac function demonstrated preserved systolic function by 48 weeks of age. Invasive studies demonstrated left ventricular hypertrophy, pulmonary congestion and impaired diastolic function. Renal function was preserved with evidence of hyperfiltration. Cardiac histological analysis demonstrated myocyte hypertrophy (p&lt;0.05) with evidence of significant interstitial fibrosis (p&lt;0.05). RT qPCR demonstrated activation of the fetal gene program, consistent with cellular hypertrophy. RAS blockade resulted in a reduction blood pressure(P&lt;0.05) cardiac interstitial fibrosis (p&lt;0.05) and activation of fetal gene program. No significant change on either systolic or diastolic function was observed, along with minimal impact upon renal structure or function. Proteomic studies demonstrated significant changes in proteins involved in oxidative phosp4horylation, mitochondrial dysfunction, beta-oxidation, and PI3K\/Akt signalling (all p&lt;0.05). Further, similar changes were observed in both LV samples from GK rats and H9C2 cells incubated in high glucose media.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>By 48 weeks of age, the diabetic GK rat demonstrates evidence of preserved systolic function and impaired relaxation, along with cardiac hypertrophy, in the presence of hyperfiltration and elevated protein excretion. These findings suggest the GK rat demonstrates some, but not all features of diabetes induced \u201ccardiorenal\u201d syndrome. This has implications for the use of this model to assess preclinical strategies to treat cardiorenal disease.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0252711","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T17:27:58Z","timestamp":1624555678000},"page":"e0252711","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Goto Kakizaki rat: Impact of age upon changes in cardiac and renal structure, function"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0221-3806","authenticated-orcid":true,"given":"Patrick","family":"Meagher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Civitarese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8158-6183","authenticated-orcid":true,"given":"Xavier","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette","family":"Bugyei-Twum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Francois","family":"Desjardins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Golam","family":"Kabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hari","family":"Kosanam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aylin","family":"Visram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Leong-Poi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Advani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim A.","family":"Connelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,6,24]]},"reference":[{"key":"pone.0252711.ref001","doi-asserted-by":"crossref","first-page":"950","DOI":"10.2337\/dc09-2326","article-title":"Incidence of type 2 diabetes using proposed HbA1c diagnostic criteria in the european prospective investigation of cancer-norfolk cohort: implications for preventive strategies","volume":"34","author":"P Chamnan","year":"2011","journal-title":"Diabetes Care. American Diabetes Association"},{"key":"pone.0252711.ref002","doi-asserted-by":"crossref","first-page":"k1497","DOI":"10.1136\/bmj.k1497","article-title":"Prevalence of diagnosed type 1 and type 2 diabetes among US adults in 2016 and 2017: population based study. BMJ","volume":"362","author":"G Xu","year":"2018","journal-title":"British Medical Journal Publishing Group"},{"key":"pone.0252711.ref003","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2337\/diacare.25.3.471","article-title":"Diabetes-related morbidity and mortality in a national sample of U.S. elders","volume":"25","author":"AG Bertoni","year":"2002","journal-title":"Diabetes Care. American Diabetes Association"},{"key":"pone.0252711.ref004","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/XCE.0000000000000116","article-title":"Epidemiology in diabetes mellitus and cardiovascular disease","volume":"6","author":"W Fan","year":"2017","journal-title":"Cardiovasc Endocrinol"},{"key":"pone.0252711.ref005","first-page":"703","author":"C Ronco","year":"2010","journal-title":"Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative"},{"key":"pone.0252711.ref006","first-page":"853","article-title":"Endothelial dysfunction in diabetes mellitus","volume":"3","author":"HAR Hadi","year":"2007","journal-title":"Vasc Health Risk Manag. Dove Press"},{"key":"pone.0252711.ref007","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.cjca.2018.02.026","article-title":"Heart Failure With Preserved Ejection Fraction in Diabetes: Mechanisms and Management","volume":"34","author":"P Meagher","year":"2018","journal-title":"Can J Cardiol"},{"key":"pone.0252711.ref008","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrneph.2010.58","article-title":"The RAAS in the pathogenesis and treatment of diabetic nephropathy","volume":"6","author":"P Ruggenenti","year":"2010","journal-title":"Nat Rev Nephrol. Nature Publishing Group"},{"key":"pone.0252711.ref009","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.cjca.2016.07.512","article-title":"Diabetes for Cardiologists: Practical Issues in Diagnosis and Management","volume":"33","author":"GBJ Mancini","year":"2017","journal-title":"Can J Cardiol"},{"key":"pone.0252711.ref010","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1007\/s13300-020-00921-y","article-title":"Kidney Disease in Type 2 Diabetes Mellitus and Benefits of Sodium-Glucose Cotransporter 2 Inhibitors: A Consensus Statement","volume":"11","author":"A Roy","year":"2020","journal-title":"Diabetes Ther. Springer Healthcare"},{"key":"pone.0252711.ref011","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.2337\/diacare.27.8.1879","article-title":"The incidence of congestive heart failure in type 2 diabetes: an update","volume":"27","author":"GA Nichols","year":"2004","journal-title":"Diabetes Care"},{"key":"pone.0252711.ref012","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes","volume":"373","author":"B Zinman","year":"2015","journal-title":"N Engl J Med. Massachusetts Medical Society"},{"key":"pone.0252711.ref013","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2217\/fca-2019-0065","article-title":"Dapagliflozin and cardiovascular outcomes in patients with Type 2 diabetes","volume":"16","author":"DY Al-Bazz","year":"2020","journal-title":"Future Cardiol. Future Medicine Ltd London, UK"},{"key":"pone.0252711.ref014","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/00325481.2018.1423852","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"130","author":"R Guthrie","year":"2018","journal-title":"Postgrad Med"},{"key":"pone.0252711.ref015","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy","volume":"380","author":"V Perkovic","year":"2019","journal-title":"N Engl J Med. Massachusetts Medical Society"},{"key":"pone.0252711.ref016","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/ndt\/gfaa234","article-title":"The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics","volume":"35","author":"DC Wheeler","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"pone.0252711.ref017","first-page":"2117","article-title":"Effect of Empagliflozin on Left Ventricular Mass in Patients with Type 2 Diabetes and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial","volume":"373","author":"S Verma","year":"2019","journal-title":"Circulation. American Heart Association Bethesda, MD"},{"key":"pone.0252711.ref018","first-page":"2178","article-title":"Diabetes in the Goto-Kakizaki rat is accompanied by impaired insulin-mediated myosin-bound phosphatase activation and vascular smooth muscle cell relaxation","volume":"49","author":"OA Sandu","year":"2000","journal-title":"Diabetes. American Diabetes Association"},{"key":"pone.0252711.ref019","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1056\/NEJMcibr0911499","article-title":"Alpha2A-adrenergic receptors and type 2 diabetes","volume":"362","author":"FM Gribble","year":"2010","journal-title":"N Engl J Med"},{"key":"pone.0252711.ref020","doi-asserted-by":"crossref","first-page":"S328","DOI":"10.1016\/j.cjca.2011.07.598","article-title":"724 Characterisation of a novel rodent model of diabetes induced heart failure with preserved ejection fraction\u2014The Goto Kakizaki rat","volume":"27","author":"M Kuliszewski","year":"2011","journal-title":"Canadian Journal of Cardiology"},{"key":"pone.0252711.ref021","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ejphar.2005.07.015","article-title":"Vasopeptidase inhibition has beneficial cardiac effects in spontaneously diabetic Goto-Kakizaki rats","volume":"519","author":"T Gr\u00f6nholm","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"pone.0252711.ref022","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1093\/cvr\/cvy131","article-title":"Sirtuin 1 activation attenuates cardiac fibrosis in a rodent pressure overload model by modifying Smad2\/3 transactivation","volume":"114","author":"A Bugyei-Twum","year":"2018","journal-title":"Cardiovasc Res"},{"key":"pone.0252711.ref023","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12933-018-0741-9","article-title":"Dual inhibition of sodium-glucose linked cotransporters 1 and 2 exacerbates cardiac dysfunction following experimental myocardial infarction","volume":"17","author":"KA Connelly","year":"2018","journal-title":"Cardiovasc Diabetol. BioMed Central"},{"key":"pone.0252711.ref024","first-page":"2408","article-title":"Early outgrowth cells release soluble endocrine antifibrotic factors that reduce progressive organ fibrosis","volume":"31","author":"DA Yuen","year":"2013","journal-title":"Stem Cells. John Wiley & Sons, Ltd"},{"key":"pone.0252711.ref025","first-page":"594","article-title":"Expression of proto-oncogenes and gene mutation of sarcomeric proteins in patients with hypertrophic cardiomyopathy","volume":"83","author":"H Kai","year":"1998","journal-title":"Circ Res. Lippincott Williams & Wilkins"},{"key":"pone.0252711.ref026","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1161\/CIRCHEARTFAILURE.108.765750","article-title":"Inhibition of protein kinase C-beta by ruboxistaurin preserves cardiac function and reduces extracellular matrix production in diabetic cardiomyopathy","volume":"2","author":"KA Connelly","year":"2009","journal-title":"Circ Heart Fail. Lippincott Williams & Wilkins"},{"key":"pone.0252711.ref027","first-page":"39551","article-title":"Suppression of NLRP3 Inflammasome Activation Ameliorates Chronic Kidney Disease-Induced Cardiac Fibrosis and Diastolic Dysfunction","volume":"6","author":"A Bugyei-Twum","year":"2016","journal-title":"Sci Rep. Nature Publishing Group"},{"key":"pone.0252711.ref028","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1210\/en.2014-1650","article-title":"CXCR4 promotes renal tubular cell survival in male diabetic rats: implications for ligand inactivation in the human kidney","volume":"156","author":"FS Siddiqi","year":"2015","journal-title":"Endocrinology"},{"key":"pone.0252711.ref029","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1021\/ac025747h","article-title":"Empirical statistical model to estimate the accuracy of peptide identifications made by MS\/MS and database search","volume":"74","author":"A Keller","year":"2002","journal-title":"Anal Chem"},{"key":"pone.0252711.ref030","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1021\/ac0341261","article-title":"A statistical model for identifying proteins by tandem mass spectrometry","volume":"75","author":"AI Nesvizhskii","year":"2003","journal-title":"Anal Chem"},{"key":"pone.0252711.ref031","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in Ingenuity Pathway Analysis","volume":"30","author":"A Kr\u00e4mer","year":"2014","journal-title":"Bioinformatics"},{"key":"pone.0252711.ref032","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/978-1-4939-8994-2_19","article-title":"Characterization of the Goto-Kakizaki (GK) Rat Model of Type 2 Diabetes","volume":"1916","author":"PC Guest","year":"2019","journal-title":"Methods Mol Biol. New York, NY: Springer New York"},{"key":"pone.0252711.ref033","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0140-6736(02)08090-X","article-title":"Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"LH Lindholm","year":"2002","journal-title":"Lancet"},{"key":"pone.0252711.ref034","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1172\/JCI117179","article-title":"Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice","volume":"93","author":"S Ishibashi","year":"1994","journal-title":"J Clin Invest. American Society for Clinical Investigation"},{"key":"pone.0252711.ref035","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrcardio.2017.65","article-title":"Epidemiology of heart failure with preserved ejection fraction","volume":"14","author":"SM Dunlay","year":"2017","journal-title":"Nat Rev Cardiol. Nature Publishing Group"},{"key":"pone.0252711.ref036","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00392-019-01505-y","article-title":"Characteristics and outcomes of HFpEF with declining ejection fraction","volume":"109","author":"JJ Park","year":"2020","journal-title":"Clin Res Cardiol. Springer Berlin Heidelberg"},{"key":"pone.0252711.ref037","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/CIRCULATIONAHA.116.025957","article-title":"The Diabetic Heart Failure With Preserved Ejection Fraction Phenotype: Is it Real and Is It Worth Targeting Therapeutically?","volume":"135","author":"BR Lindman","year":"2017","journal-title":"Circulation"},{"key":"pone.0252711.ref038","first-page":"43","article-title":"Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension","volume":"117","author":"L van Heerebeek","year":"2008","journal-title":"Circulation. Lippincott Williams & Wilkins"},{"key":"pone.0252711.ref039","first-page":"1123","article-title":"Myocardial cell death in human diabetes","volume":"87","author":"A Frustaci","year":"2000","journal-title":"Circ Res. Lippincott Williams & Wilkins"},{"key":"pone.0252711.ref040","first-page":"2136","article-title":"Diabetic Cardiomyopathy: Does the Type of Diabetes Matter?","volume":"17","author":"ME H\u00f6lscher","year":"2016","journal-title":"Int J Mol Sci. Multidisciplinary Digital Publishing Institute"},{"key":"pone.0252711.ref041","first-page":"1415","article-title":"Recipes for creating animal models of diabetic cardiovascular disease","volume":"100","author":"W Hsueh","year":"2007","journal-title":"Circ Res. Lippincott Williams & Wilkins"},{"key":"pone.0252711.ref042","first-page":"2974304","article-title":"Calcium Signaling in the Ventricular Myocardium of the Goto-Kakizaki Type 2 Diabetic Rat","volume":"2018","author":"L Kury Al","year":"2018","journal-title":"J Diabetes Res. Hindawi"},{"key":"pone.0252711.ref043","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.286.4.421","article-title":"Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals","volume":"286","author":"HC Gerstein","year":"2001","journal-title":"JAMA. American Medical Association"},{"key":"pone.0252711.ref044","doi-asserted-by":"crossref","first-page":"F1450","DOI":"10.1152\/ajprenal.00246.2019","article-title":"Progression of diabetic kidney disease in T2DN rats","volume":"317","author":"O Palygin","year":"2019","journal-title":"Am J Physiol Renal Physiol. American Physiological Society Bethesda, MD"},{"key":"pone.0252711.ref045","article-title":"Comparison of the Development Diabetic Induced Renal Disease in Strains of Goto-Kakizaki Rats","volume":"Suppl 9","author":"N Kojima","year":"2013","journal-title":"J Diabetes Metab"},{"key":"pone.0252711.ref046","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(99)12323-7","article-title":"Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"pone.0252711.ref047","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1080\/03007995.2019.1576479","article-title":"The role of sodium glucose cotransporter-2 (SGLT-2) inhibitors in heart failure and chronic kidney disease in type 2 diabetes","volume":"35","author":"V Woo","year":"2019","journal-title":"Curr Med Res Opin. Taylor & Francis"},{"key":"pone.0252711.ref048","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1056\/NEJMe1607413","article-title":"Cardiac and Renovascular Complications in Type 2 Diabetes\u2014Is There Hope?","volume":"375","author":"JR Ingelfinger","year":"2016","journal-title":"N Engl J Med. Massachusetts Medical Society"},{"key":"pone.0252711.ref049","first-page":"29905","article-title":"Cytochrome c-mediated apoptosis in cells lacking mitochondrial DNA. Signaling pathway involving release and caspase 3 activation is conserved","volume":"274","author":"S Jiang","year":"1999","journal-title":"J Biol Chem. American Society for Biochemistry and Molecular Biology"},{"key":"pone.0252711.ref050","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.mce.2016.04.006","article-title":"Lipocalin-2 inhibits autophagy and induces insulin resistance in H9c2 cells","volume":"430","author":"YK Chan","year":"2016","journal-title":"Mol Cell Endocrinol"},{"key":"pone.0252711.ref051","doi-asserted-by":"crossref","first-page":"698","DOI":"10.7150\/ijms.19800","article-title":"Autophagy was involved in the protective effect of metformin on hyperglycemia-induced cardiomyocyte apoptosis and Connexin43 downregulation in H9c2 cells","volume":"14","author":"G-Y Wang","year":"2017","journal-title":"Int J Med Sci"},{"key":"pone.0252711.ref052","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11626-010-9368-1","article-title":"The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro","volume":"47","author":"SJ Watkins","year":"2011","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"pone.0252711.ref053","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes","volume":"375","author":"SP Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"pone.0252711.ref054","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes","volume":"375","author":"SP Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"pone.0252711.ref055","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","article-title":"Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus","volume":"369","author":"BM Scirica","year":"2013","journal-title":"N Engl J Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0252711","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T17:28:54Z","timestamp":1624555734000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0252711"}},"subtitle":[],"editor":[{"given":"Vincenzo","family":"Lionetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,6,24]]},"references-count":55,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0252711","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,24]]}}}